Ipsen Outpaces Market With Lucrative Priority Review Voucher Deal

 
• By Kevin Grogan
  
queue
Ipsen sold the PRV received with the approval of Sohonos. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Rare Diseases

More from Pink Sheet